Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 100 |
| Gross Profit | N/A | N/A | N/A | N/A | 100 |
| Operating Expenses | 8,235 | 11,387 | 2,239 | 9,259 | 4,888 |
| Operating Income | -8,235 | -11,387 | -2,239 | -9,259 | -4,788 |
| Interest Expense | -25 | 2,082 | 653 | 16 | 34 |
| Other Income | 3 | 432 | -325 | -28 | 0 |
| Pre-tax Income | -8,207 | -13,037 | -3,217 | -9,303 | -4,822 |
| Net Income Continuous | -8,207 | -13,037 | -3,217 | -9,303 | -4,822 |
| Net Income | $-8,207 | $-13,037 | $-3,217 | $-9,303 | $-4,822 |
| EPS Basic Total Ops | -55.21 | -5,018.09 | -5,517.81 | -65,994.57 | -49,728.30 |
| EPS Basic Continuous Ops | -44.78 | -5,018.09 | -5,515.16 | -66,099.59 | -49,734.28 |
| EPS Diluted Total Ops | -55.21 | -5,018.09 | -5,517.81 | -65,994.57 | -49,728.30 |
| EPS Diluted Continuous Ops | -44.78 | -5,018.09 | -5,515.16 | -66,099.59 | -49,734.28 |
| EPS Diluted Before Non-Recurring Items | -55.21 | -6,247.62 | -32,067.79 | -65,994.56 | -49,728.30 |
| EBITDA(a) | $-8,231 | $-9,279 | $-2,019 | $-9,154 | $-4,714 |